Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

caffeine-based cream

A topical cream containing the alkaloid caffeine in a lipoderm base, with potential anti-inflammatory, anti-fibrotic, protective and antioxidant activities. Upon topical application of the caffeine-based cream to the affected area(s), the caffeine inhibits phosphodiesterase (PDE) activity, thereby stimulating the degradation of fats during lipolysis. Caffeine also reduces the levels of certain pro-inflammatory cytokines, such as the profibrotic cytokine transforming growth factor beta (TGFb,) and matrix metalloproteinases (MMPs), thereby preventing inflammation and protecting against collagen degradation. In addition, caffeine protects cells from oxidative stress. This may help protect skin, reduce skin-related complications and improve skin appearance.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:caffeine based cream
caffeine-containing lipoderm cream
caffeine-lipoderm cream
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search